Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 2.95%
March 31, 2026 0.34%
December 31, 2025 -16.21%
September 30, 2025 16.72%
June 30, 2025 -1.03%
March 31, 2025 -0.02%
December 31, 2024 -27.49%
September 30, 2024 -0.14%
June 30, 2024 -6.96%
March 31, 2024 25.01%
December 31, 2023 10.78%
September 30, 2023 41.81%
June 30, 2023 4.73%
March 31, 2023 26.08%
December 31, 2022 33.93%
September 30, 2022 20.54%
June 30, 2022 25.44%
March 31, 2022 34.79%
December 31, 2021 57.72%
September 30, 2021 36.84%
June 30, 2021 46.22%
March 31, 2021 55.91%
December 31, 2020 49.93%
September 30, 2020 51.04%
June 30, 2020 31.74%
Date Value
March 31, 2020 31.52%
December 31, 2019 39.18%
September 30, 2019 32.37%
June 30, 2019 30.55%
March 31, 2019 31.39%
December 31, 2018 30.23%
September 30, 2018 28.35%
June 30, 2018 27.67%
March 31, 2018 37.27%
December 31, 2017 22.89%
September 30, 2017 31.31%
June 30, 2017 28.89%
March 31, 2017 33.58%
December 31, 2016 30.36%
September 30, 2016 36.88%
June 30, 2016 34.57%
March 31, 2016 36.98%
December 31, 2015 32.64%
September 30, 2015 33.99%
June 30, 2015 38.73%
March 31, 2015 38.82%
December 31, 2014 39.83%
September 30, 2014 35.38%
June 30, 2014 31.67%
March 31, 2014 28.53%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 52.64%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%
Baxter International, Inc. 33.55%

Gross Profit Margin (Quarterly) Related Metrics